Clinical Trial Update: Supplementation of L-arginine in Patients With Non-resectable Brain Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating supplementation with L-arginine in patients with unresectable brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Instituto de Oncología Ángel H. Roffo | Conditions: Unresectable Multiple Brain Metastases | Phase 1, Phase 2 | Status: COMPLETED